New studies have expanded understanding of host-pathogen interactions critical to infectious disease therapeutics. A genome-wide siRNA screen identified key human proteins essential for SARS-CoV-2 replication, highlighting novel host-directed drug targets that may overcome viral evolution challenges. Additionally, metagenomic sequencing revealed lung virome shifts preceding hospital-acquired pneumonia, offering potential early diagnostic markers. These insights provide promising avenues for antiviral development and infection management.